Trulicity 4.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF0F1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,107
Award facts
- Contract value 100% obligated
- $4,106.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,106.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pen injectors. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal government healthcare systems, particularly the military and veteran populations through the DLA Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical is also planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards to enhance competition and capability across the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FF0F1?
SPE2DR26FF0F1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FF0F1 worth?
The government has obligated $4,107 on SPE2DR26FF0F1.
Is contract SPE2DR26FF0F1 an order under another contract?
Yes. SPE2DR26FF0F1 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF0F1 competed?
The extent of competition for SPE2DR26FF0F1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award